Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Takeda Pharmaceutical (TAK) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $0.89.

  • Takeda Pharmaceutical's Shares Outstanding (Weighted Average) rose 142.86% to $0.89 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.89, marking a year-over-year increase of 142.86%. This contributed to the annual value of $0.45 for FY2025, which is 2972.14% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Shares Outstanding (Weighted Average) of $0.89 as of Q4 2025, which was up 142.86% from $0.49 recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Shares Outstanding (Weighted Average) ranged from a high of $2.27 in Q1 2021 and a low of $0.18 during Q3 2023
  • Over the past 5 years, Takeda Pharmaceutical's median Shares Outstanding (Weighted Average) value was $0.79 (recorded in 2022), while the average stood at $0.86.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Shares Outstanding (Weighted Average) soared by 77157.49% in 2021, and later tumbled by 7644.25% in 2023.
  • Takeda Pharmaceutical's Shares Outstanding (Weighted Average) (Quarter) stood at $1.36 in 2021, then decreased by 3.75% to $1.3 in 2022, then plummeted by 51.21% to $0.64 in 2023, then skyrocketed by 38.16% to $0.88 in 2024, then rose by 1.43% to $0.89 in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $0.89 for Q4 2025, versus $0.49 for Q3 2025 and $0.55 for Q2 2025.